# Heterogeneity of glucose metabolism and uptake identifies distinct cancer cell and cancer stem cell phenotypes

**Authors:** Zuzana Tylichova, Martin Krkoska, Vaclav Hrabal, Michaela Stenckova, Borivoj Vojtesek, Philip J. Coates

PMC · DOI: 10.1186/s11658-025-00837-0 · 2026-01-17

## TL;DR

Tumor cells show varied glucose metabolism, with some resembling cancer stem cells that have unique metabolic features.

## Contribution

The study reveals coexistence of glycolysis and oxidative respiration in cancer cells, challenging the Warburg effect paradigm.

## Key findings

- High glucose uptake correlates with high mitochondrial membrane potential in tumor cells.
- Metabolic profiles in tumor cells are heterogeneous and not fixed.
- Subpopulations with both high glucose uptake and mitochondrial activity exist.

## Abstract

Tumor cells show phenotypic heterogeneity, including a small subpopulation of cancer stem-like cells (CSCs) that are responsible for maintaining tumor growth and metastasis. Altered glucose metabolism is a characteristic feature of cancer cells, which often display increased aerobic glycolysis alongside mitochondrial oxidative respiration (the Warburg effect). However, there is evidence that CSCs exhibit distinct glucose metabolism compared with the tumor cell bulk, with increased mitochondrial activity and oxidative respiration. Thus, identifying individual cells with different modes of glucose metabolism may serve as a common identifier of CSCs, and these metabolic differences would allow selective therapeutic targeting.

We investigated the levels of enzymes involved in glycolysis and oxidative respiration, together with glucose uptake and mitochondrial membrane potential in individual cancer cells. These parameters were correlated with each other and with CSC markers.

We show considerable heterogeneity of metabolic markers in individual tumor cells. Surprisingly, high glucose uptake correlates with high mitochondrial membrane potential, indicating that increased oxidative respiration and aerobic glycolysis coexist rather than showing an inverse correlation. We also show that colonies derived from cells with high mitochondrial membrane potential exhibit heterogeneous metabolic parameters, demonstrating that metabolic profiles are not hard-wired. Public gene expression profiling data indicated similar inconsistent metabolic features of CSCs.

The data reveal inherent heterogeneity and plasticity of glucose metabolism and mitochondrial membrane potential in tumor cells, with evidence for a subpopulation that possesses both increased glucose uptake and increased mitochondrial membrane potential, with implications for therapeutic targeting of metabolism in cancer.

The online version contains supplementary material available at 10.1186/s11658-025-00837-0.

## Full-text entities

- **Genes:** SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, CYC1 (cytochrome c1) [NCBI Gene 1537] {aka MC3DN6, UQCR4}, Prom1 (prominin 1) [NCBI Gene 19126] {aka 4932416E19Rik, AC133, CD133, Prom, Prom-1, Proml1}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}, LDHA (lactate dehydrogenase A) [NCBI Gene 3939] {aka GSD11, HEL-S-133P, LDHM, PIG19}, ACACA (acetyl-CoA carboxylase alpha) [NCBI Gene 31] {aka ACAC, ACACAD, ACACalpha, ACC, ACC1, ACCA}, Aldh3a1 (aldehyde dehydrogenase family 3, subfamily A1) [NCBI Gene 11670] {aka Ahd-4, Ahd4, Aldh, Aldh3}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, SLC16A3 (solute carrier family 16 member 3) [NCBI Gene 9123] {aka MCT 3, MCT 4, MCT-3, MCT-4, MCT3, MCT4}, PROM1 (prominin 1) [NCBI Gene 8842] {aka AC133, CD133, CORD12, MCDR2, MSTP061, PROML1}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, VDAC1 (voltage dependent anion channel 1) [NCBI Gene 7416] {aka PORIN, VDAC-1}, IDH3A (isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha) [NCBI Gene 3419] {aka RP90}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}, SDHA (succinate dehydrogenase complex flavoprotein subunit A) [NCBI Gene 6389] {aka CMD1GG, FP, MC2DN1, NDAXOA, PGL5, PPGL5}, SDHAF1 (succinate dehydrogenase complex assembly factor 1) [NCBI Gene 644096] {aka LYRM8, MC2DN2}, SDHB (succinate dehydrogenase complex iron sulfur subunit B) [NCBI Gene 6390] {aka CWS2, IP, MC2DN4, PGL4, PPGL4, SDH}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, PDK1 (pyruvate dehydrogenase kinase 1) [NCBI Gene 5163], ACLY (ATP citrate lyase) [NCBI Gene 47] {aka ACL, ATPCL, CLATP}, TOMM40 (translocase of outer mitochondrial membrane 40) [NCBI Gene 10452] {aka C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, Lgr5 (leucine rich repeat containing G protein coupled receptor 5) [NCBI Gene 14160] {aka FEX, Gpr49}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, PDK4 (pyruvate dehydrogenase kinase 4) [NCBI Gene 5166], IDH2 (isocitrate dehydrogenase (NADP(+)) 2) [NCBI Gene 3418] {aka D2HGA2, ICD-M, IDH, IDH-2, IDHM, IDP}, TALDO1 (transaldolase 1) [NCBI Gene 6888] {aka TAL, TAL-H, TALDOR, TALH}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, Cd24a (CD24a antigen) [NCBI Gene 12484] {aka Cd24, HSA, Ly-52, nectadrin}, NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5) [NCBI Gene 4698] {aka B13, CI-13KD-B, CI-13kB, NUFM, UQOR13}
- **Diseases:** head-and-neck squamous cell carcinoma (MESH:D000077195), melanoma (MESH:D008545), Cancer (MESH:D009369), metastasis (MESH:D009362), Squamous cancer (MESH:D018307), breast cancer (MESH:D001943)
- **Chemicals:** sodium lactate (MESH:D019354), formaldehyde (MESH:D005557), verapamil (MESH:D014700), lipid (MESH:D008055), Fatty acids (MESH:D005227), Glucose (MESH:D005947), 18F-fluorodeoxyglucose (MESH:D019788), 5-cyano-2,3-di-(p-tolyl)tetrazolium chloride (-), metformin (MESH:D008687), glutamine (MESH:D005973), 2-deoxy-d-glucose (MESH:D003847), AF647 (MESH:C569686), lactate (MESH:D019344), 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (MESH:C098340), streptomycin (MESH:D013307), propidium iodide (MESH:D011419), EtOH (MESH:D000431), pentose phosphate (MESH:D010428), valinomycin (MESH:D014634), Triton-X (MESH:D017830), sodium azide (MESH:D019810), penicillin (MESH:D010406), carbon (MESH:D002244), oxygen (MESH:D010100), NAD+ (MESH:D009243), TCA (MESH:D014233), CO2 (MESH:D002245), NBT (MESH:C094100)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** XC-A4122 — Rattus norvegicus (Rat), Rat sarcoma, Cancer cell line (CVCL_1891), FaDu — Homo sapiens (Human), Hypopharyngeal squamous cell carcinoma, Cancer cell line (CVCL_1218), A375 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0132), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829025/full.md

---
Source: https://tomesphere.com/paper/PMC12829025